180 related articles for article (PubMed ID: 37249796)
61. Mixed neuroendocrine non-neuroendocrine neoplasm: a case report and review.
Hiroi S; Yamamoto R; Hamaoka M; Hoshino M; Sasaki T; Matsugu Y; Nishisaka T; Nakahara H; Itamoto T
Clin J Gastroenterol; 2022 Feb; 15(1):244-255. PubMed ID: 34796444
[TBL] [Abstract][Full Text] [Related]
62. Insulinoma-associated protein 1 immunostaining on cytology specimens: an institutional experience.
Rodriguez EF; Fite JJ; Chowsilpa S; Maleki Z
Hum Pathol; 2019 Mar; 85():128-135. PubMed ID: 30502379
[TBL] [Abstract][Full Text] [Related]
63. Mucin phenotype expression of gastric neuroendocrine neoplasms: analysis of histopathology and carcinogenesis.
Domori K; Nishikura K; Ajioka Y; Aoyagi Y
Gastric Cancer; 2014 Apr; 17(2):263-72. PubMed ID: 23828549
[TBL] [Abstract][Full Text] [Related]
64. [Classification of pancreatic neuroendocrine tumours: Changes made in the 2017 WHO classification of tumours of endocrine organs and perspectives for the future].
Scoazec JY; Couvelard A;
Ann Pathol; 2017 Dec; 37(6):444-456. PubMed ID: 29169836
[TBL] [Abstract][Full Text] [Related]
65. The expression of TTF1, CDX2 and ISL1 in 74 poorly differentiated neuroendocrine carcinomas.
Lee H; Fu Z; Koo BH; Sheehan CE; Young GQ; Lin J; Patil DT; Yang Z
Ann Diagn Pathol; 2018 Dec; 37():30-34. PubMed ID: 30236546
[TBL] [Abstract][Full Text] [Related]
66. Neuroendocrine neoplasms of the pancreas: diagnosis and pitfalls.
Konukiewitz B; Jesinghaus M; Kasajima A; Klöppel G
Virchows Arch; 2022 Feb; 480(2):247-257. PubMed ID: 34647171
[TBL] [Abstract][Full Text] [Related]
67. ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas.
Garcia-Carbonero R; Sorbye H; Baudin E; Raymond E; Wiedenmann B; Niederle B; Sedlackova E; Toumpanakis C; Anlauf M; Cwikla JB; Caplin M; O'Toole D; Perren A;
Neuroendocrinology; 2016; 103(2):186-94. PubMed ID: 26731334
[No Abstract] [Full Text] [Related]
68. Acinar neoplasms of the pancreas-A summary of 25 years of research.
Klimstra DS; Adsay V
Semin Diagn Pathol; 2016 Sep; 33(5):307-18. PubMed ID: 27320062
[TBL] [Abstract][Full Text] [Related]
69. Chromosomal and molecular pathway alterations in the neuroendocrine carcinoma and adenocarcinoma components of gastric mixed neuroendocrine-nonneuroendocrine neoplasm.
Sun L; Zhang J; Wang C; Zhao S; Shao B; Guo Y; Liu Y; Sun Y
Mod Pathol; 2020 Dec; 33(12):2602-2613. PubMed ID: 32461621
[TBL] [Abstract][Full Text] [Related]
70. Clinicopathological features and prognostic factors associated with gastroenteropancreatic mixed neuroendocrine non-neuroendocrine neoplasms in Chinese patients.
Huang YC; Yang NN; Chen HC; Huang YL; Yan WT; Yang RX; Li N; Zhang S; Yang PP; Feng ZZ
World J Gastroenterol; 2021 Feb; 27(7):624-640. PubMed ID: 33642833
[TBL] [Abstract][Full Text] [Related]
71. Evidence of a common cell origin in a case of pancreatic mixed intraductal papillary mucinous neoplasm-neuroendocrine tumor.
Schiavo Lena M; Cangi MG; Pecciarini L; Francaviglia I; Grassini G; Maire R; Partelli S; Falconi M; Perren A; Doglioni C
Virchows Arch; 2021 Jun; 478(6):1215-1219. PubMed ID: 33005981
[TBL] [Abstract][Full Text] [Related]
72. Pancreatic acinar cell carcinoma with endocrine differentiation: immunohistochemical and ultrastructural analyses.
Tobita K; Kijima H; Chino O; Dowaki S; Kashiwagi H; Tanaka M; Ohtani Y; Inokuchi S; Makuuchi H
Anticancer Res; 2001; 21(3C):2131-4. PubMed ID: 11501836
[TBL] [Abstract][Full Text] [Related]
73. Clinicopathological features and outcome of type 3 gastric neuroendocrine tumours.
Min BH; Hong M; Lee JH; Rhee PL; Sohn TS; Kim S; Kim KM; Kim JJ
Br J Surg; 2018 Oct; 105(11):1480-1486. PubMed ID: 29893418
[TBL] [Abstract][Full Text] [Related]
74. Diagnostic and Predictive Role of DLL3 Expression in Gastroenteropancreatic Neuroendocrine Neoplasms.
Liverani C; Bongiovanni A; Mercatali L; Pieri F; Spadazzi C; Miserocchi G; Di Menna G; Foca F; Ravaioli S; De Vita A; Cocchi C; Rossi G; Recine F; Ibrahim T
Endocr Pathol; 2021 Jun; 32(2):309-317. PubMed ID: 33409812
[TBL] [Abstract][Full Text] [Related]
75. Cytomorphologic and immunophenotypical features of acinar cell neoplasms of the pancreas.
Sigel CS; Klimstra DS
Cancer Cytopathol; 2013 Aug; 121(8):459-70. PubMed ID: 23408736
[TBL] [Abstract][Full Text] [Related]
76. [Advances of pathological diagnosis and molecular pathology of lung neuroendocrine neoplasms].
Wu JH; Zhu YL; Wang HY; Liu YH; Lin DM
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):109-115. PubMed ID: 38281776
[TBL] [Abstract][Full Text] [Related]
77. [Pancreatic neuroendocrine tumour - laparoscopic distal pancreatectomy with splenectomy and partial gastric resection].
Mittermair R
Zentralbl Chir; 2013 Dec; 138(6):593-5. PubMed ID: 24399463
[TBL] [Abstract][Full Text] [Related]
78. Gastric mixed neuroendocrine/non neuroendocrine neoplasia: a rare entity.
Costa JDE; Costa RS; Moreira HD; Ferreira A
Rev Esp Enferm Dig; 2023 Nov; 115(11):670-671. PubMed ID: 37882193
[TBL] [Abstract][Full Text] [Related]
79. Mixed acinar-endocrine carcinoma of the pancreas--a case report.
Cho KJ; Kim JY; Lee SS; Khang SK; Kim CW
J Korean Med Sci; 1996 Apr; 11(2):188-92. PubMed ID: 8835769
[TBL] [Abstract][Full Text] [Related]
80. DNA methylation reveals distinct cells of origin for pancreatic neuroendocrine carcinomas and pancreatic neuroendocrine tumors.
Simon T; Riemer P; Jarosch A; Detjen K; Di Domenico A; Bormann F; Menne A; Khouja S; Monjé N; Childs LH; Lenze D; Leser U; Rossner F; Morkel M; Blüthgen N; Pavel M; Horst D; Capper D; Marinoni I; Perren A; Mamlouk S; Sers C
Genome Med; 2022 Mar; 14(1):24. PubMed ID: 35227293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
